Graves Disease Forecast in 23 Major Markets 2017-2027 - Market Split by Gender and 5-Year age Cohort

Dublin, Jan. 10, 2018 -- The "Graves Disease Forecast in 23 Major Markets 2017-2027" report has been added to Research and Markets' offering.

Graves' disease is an autoimmune disease of the thyroid gland, in which the thyroid attacked by the body's own defence mechanisms becomes enlarged and produces increased amount of hormones, causing hyperthyroidism. The condition induces signs and symptoms that seriously affect the patient's quality of life, everyday activities and ability to work.

This report provides the current prevalent population for Graves' disease across 23 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, The Netherlands, Norway, Sweden, Austria, Denmark, Iceland, Switzerland, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight, several of the main symptoms and co-morbidities of Graves' disease have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

The quantified symptoms and co-morbidities for Graves' disease include:

• Graves' Ophthalmopathy
• Acropachy
• Thyroid dermopathy

Moreover, forecasts of some clinical and family history parameters are provided at a country level.

Reasons to Buy:

• Able to quantify patient populations in global Graves' disease's market to target the development of future products, pricing strategies and launch plans
• Gain further insight into the prevalence of the subdivided types of Graves' disease and identify patient segments with high potential
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries
• Provide a level of understanding on the impact from specific co-morbid conditions on Graves' disease's prevalent population
• Identify sub-populations within Graves' disease which require treatment
• Gain an understanding of the specific markets that have the largest number of Crohn's disease patients

Key Topics Covered:

1. Introduction
2. Cause of the Disease
3. Risk Factors & Prevention
4. Diagnosis of the Disease
5. Variation by Geography/Ethnicity
6. Disease Prognosis & Clinical Course
7. Key Comorbid Conditions / Features Associated With the Disease
8. Methodology for Quantification of Patient Numbers
9. Top-Line Prevalence for Graves' Disease
10. Features of Graves' Disease Patients
11. Comorbid Conditions of Graves' Disease Patients
12. Abbreviations Used in the Report
13. Other Publications
14. Online Patient-Based Databases
15. Patient-Based Offering
16. Online Pricing Data & Platforms
17. References
18. Appendix
    

For more information about this report visit https://www.researchandmarkets.com/research/s4c7hm/graves_disease?w=12

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Endocrine and Metabolic Disorders Drugs